Sasa Health exerts a protective effect on Her2/NeuN mammary tumorigenesis

Anticancer Research

Volumn 24, Issue 5 A, 2004, Pages 2879-2884

  Ren, Mingqiang ^a   Reilly, R Todd ^b   Sacchi, Nicoletta ^a  

^a ROSWELL PARK CANCER INSTITUTE   (United States)

^b JOHNS HOPKINS UNIVERSITY   (United States)

Author keywords

Bamboo grass leaves; Chemoprevention; Her2 NeuN; Mammary tumor; Sasa Health

Indexed keywords

EPIDERMAL GROWTH FACTOR RECEPTOR 2; PLANT EXTRACT; SASA EXTRACT; SASA HEALTH; UNCLASSIFIED DRUG;

ADOLESCENT; AGED; ANGIOGENESIS; ANIMAL MODEL; ANIMAL TISSUE; ANTINEOPLASTIC ACTIVITY; ARTICLE; BREAST CARCINOGENESIS; BREAST CARCINOMA; BREAST DEVELOPMENT; BREAST DUCT; CANCER MODEL; CONTROLLED STUDY; FEMALE; METASTASIS; MOUSE; NONHUMAN; ONCOGENE NEU; PLANT LEAF; PRIORITY JOURNAL; SASA; SASA SENANENSIS REHDER; TRANSGENIC MOUSE;

ANIMALS; FEMALE; GENES, ERBB-2; MAMMARY GLANDS, ANIMAL; MAMMARY NEOPLASMS, EXPERIMENTAL; MICE; MICE, TRANSGENIC; NEOPLASM METASTASIS; PHYTOTHERAPY; PLANT EXTRACTS; RECEPTOR, ERBB-2; SASA;

EID: 6444240103     PISSN: 02507005     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (19)

1. Tsunoda S, Yamamoto K, Sakamoto S, Inoue H and Nagasawa H: Effects of Sasa Health, extract of bamboo grass leaves, on spontaneous mammary tumorigenesis in SHN mice. Anticancer Res 18: 153-158, 1998.
2. Surh YJ: Cancer chemoprevention with dietary phytochemicals. Nat Rev Cancer 3: 768-780, 2003.
3. Campbell MJ, Hamilton B, Shoemaker M, Tagliaferri M, Cohen I and Tripathy D: Antiproliferative activity of Chinese medicinal herbs on breast cancer cells in vitro. Anticancer Res 22: 3843-3852, 2002.
4. Alexandrova R, Alexandrova I, Velcheva M and Varadinova T: Phytoproducts and cancer. Exp Pathol Parasitol 4: 15-26, 2000.
5. Shibata M, Fujii M and Yamaguchi R: Pharmacological studies on bamboo grass. IV. Toxicological and pharmacological effects of the extract (Fill) obtained from Sasa albomarginata Makino et Shibata (author's transi). Yakugaku Zasshi 99: 663-668, 1979.
6. Yamafuji K and Murakami H: Antitumor potency of lignin and pyrocatechol and their action on deoxyribonucleic acid. Enzymologia 35: 139-153, 1968.
7. Suzuki S, Saito T, Uchiyama M and Akiya S: Studies on the anti-tumor activity of polysaccharides. I. Isolation of hemicelluloses from Yakushima-bamboo and their growth inhibitory activities against sarcoma-180 solid tumor. Chem Phar Bull 16: 2032-2039, 1968.
8. Raidaru G, Ilomets T, Mottus A and Maser M: Isolation of polysaccharides with antitumor activity from Sasa Kurilensis (Fr. et Sar.). Exp Oncol 20: 34-39, 1997.
9. Egner PA, Munoz A and Kensler TW: Chemoprevention with chlorophyllin in individuals exposed to dietary aflatoxin. Mutat Res 523-524: 209-216, 2003.
10. Kobayashi M, Tsunoda S, Inoue H, Iijima K, Toriizuka K, Cyong JC and Nagasawa H: Effects of Sasa Health, extract of bamboo grass leaves, on the thymic involution and thymocyte phenotypic alterations in SHN female mice. Bull Fac Agr Meiji Univ 115: 39-44, 1998.
11. Ohizumi T, Shirasaki K, Tabata T, Nakayama S, Okzaki M and Sakamoto K: Pharmacological studies of Sasa senanensis rehder extract on anti-inflammatory effect and phagocytic activity. J Showa Med Assoc 48: 595-600, 1988.
12. Boik J: Natural compounds that affect the immune system. In: Natural Compounds in Cancer Therapy (Farnell S. ed). Princeton, Oregon Medical Press, 2001, pp 131-144.
13. Guy CT, Webster MA, Schaller M, Parsons TJ, Cardiff RD and Muller WJ: Expression of the neu protooncogene in the mammary epithelium of transgenic mice induces metastatic disease. Proc Natl Acad Sci USA 89: 10578-10582, 1992.
14. Reilly RT, Machiels JP, Emens LA, Ercolini AM, Okoye FI, Lei RY, Weintraub D and Jaffee EM: The collaboration of both humoral and cellular HER-2/neu-targeted immune responses is required for the complete eradication of HER-2/neu-expressing tumors. Cancer Res 61: 880-883, 2001.
15. Reilly RT, Gottlieb MB, Ercolini AM, Machiels JP, Kane CE, Okoye FI, Muller WJ, Dixon KH and Jaffee EM: HER-2/neu is a tumor rejection target in tolerized HER-2/neu transgenic mice. Cancer Res 60: 3569-3576, 2000.
16. Sirchia SM, Ren M, Pili R, Sironi E, Somenzi G, Ghidoni R, Toma S, Nicolo G and Sacchi N: Endogenous reactivation of the RARbeta2 tumor suppressor gene epigenetically silenced in breast cancer. Cancer Res 62: 2455-2461, 2002.
17. Webster MA, Hutchinson JN, Rauh MJ, Muthuswamy SK, Anton M, Tortorice CG, Cardiff RD, Graham FL, Hassell JA and Muller WJ: Requirement for both She and phosphatidylinositol 3' kinase signaling pathways in polyomavirus middle T-mediated mammary tumorigenesis. Mol Cell Biol 18: 2344-2359, 1998.
18. Zhou H, Chen WD, Qin X, Lee K, Liu L, Markowitz SD and Gerson SL: MMTV promoter hypomethylation is linked to spontaneous and MNU associated c-neu expression and mammary carcinogenesis in MMTV c-neu transgenic mice. Oncogene 20: 6009-6017, 2001.
19. Nanni P, Nicoletti G, De Giovanni C, Landuzzi L, Di Carlo E, Iezzi M, Ricci C, Astolfi A, Croci S, Marangoni F, Musiani P, Forni G and Lollini PL: Prevention of HER-2/neu transgenic mammary carcinoma by tamoxifen plus interleukin 12. Int J Cancer 105: 384-389, 2003.